Literature DB >> 10102645

Distribution of TNF-alpha, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-alpha is distributed mainly in the vicinity of TNF receptors in the deeper layers.

S Alsalameh1, K Winter, R Al-Ward, J Wendler, J R Kalden, R W Kinne.   

Abstract

The expression of TNF-alpha and its receptors in the rheumatoid synovial membrane was investigated using immunohistochemistry and immunocytofluorescence. TNF-alpha+ cells (< 10% of all cells) were found in all regions, predominantly in sublining and diffuse infiltrates. The highest percentage of TNF-R+ cells was found in the lining layer (50-90%), with a slight predominance of TNF-R55. In the sublining, fewer cells expressed TNF-R (approximately 50%), mostly TNF-R75. TNF-R75+ cells were also detectable in diffuse infiltrates and lymphoid aggregates (10-50%). These contained only individual TNF-R55+ cells. In diffuse infiltrates, there were slightly more TNF-R55+ cells than in lymphoid aggregates (in both cases < 10%). In sequential sections, TNF-alpha+ cells localized mostly in the vicinity of TNF-R+ cells. Macrophage-like cells appeared to be the predominant TNF-R+ cell type. CD3+ T cells in lymphoid aggregates expressed exclusively TNF-R75. Subsequently, the expression of membrane-bound TNF-alpha, TNF-R55 and TNF-R75 was tested by FACS analysis in isolated RA synoviocytes (n = 7 patients). Only four specimens expressed mTNF-alpha, and that on a low percentage of cells (2 +/- 2.4%; mean +/- SD). In contrast, all specimens expressed higher percentages of TNF-R55 and TNF-R75 (21 +/- 1% and 14 +/- 7.1%, respectively). These results demonstrate that: (1) the percentage of cells expressing soluble/transmembrane TNF-alpha is greatly outnumbered by the percentage of cells expressing TNF receptors; and (2) TNF-alpha-expressing cells are localized in regions expressing substantial levels of TNF receptors. Therefore, the known pro-inflammatory and pro-arthritic effects of TNF-alpha are probably mediated by local interactions between the receptors and their soluble and transmembrane ligands.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102645     DOI: 10.1046/j.1365-3083.1999.00458.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  17 in total

1.  Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis.

Authors:  Elke Kunisch; Muktheshwar Gandesiri; Reneé Fuhrmann; Andreas Roth; Rando Winter; Raimund W Kinne
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

Review 2.  TNF in the era of immune checkpoint inhibitors: friend or foe?

Authors:  Allen Y Chen; Jedd D Wolchok; Anne R Bass
Journal:  Nat Rev Rheumatol       Date:  2021-03-08       Impact factor: 20.543

Review 3.  PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases.

Authors:  C K Edwards
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

4.  In vivo expression of inflammatory cytokine receptors in the joint compartments of patients with arthritis.

Authors:  Tania Silvestri; Lia Pulsatelli; Paolo Dolzani; Luigi Frizziero; Andrea Facchini; Riccardo Meliconi
Journal:  Rheumatol Int       Date:  2005-03-16       Impact factor: 2.631

Review 5.  B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature.

Authors:  Ozlem Pala; Alain Diaz; Bonnie B Blomberg; Daniela Frasca
Journal:  Clin Ther       Date:  2018-05-23       Impact factor: 3.393

6.  Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis.

Authors:  Anna Neve; Addolorata Corrado; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2013-07-04       Impact factor: 3.984

7.  Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation.

Authors:  K Nissler; D Pohlers; M Hückel; J Simon; R Bräuer; R W Kinne
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

8.  Polymorphism in the tumor necrosis factor-alpha gene promoter is associated with severity of rheumatoid arthritis in the Czech population.

Authors:  Petr Nemec; Monika Pavkova-Goldbergova; Martina Stouracova; Anna Vasku; Miroslav Soucek; Jindra Gatterova
Journal:  Clin Rheumatol       Date:  2007-06-12       Impact factor: 2.980

9.  Tumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivo.

Authors:  Birgit Görtz; Silvia Hayer; Birgit Tuerck; Jochen Zwerina; Josef S Smolen; Georg Schett
Journal:  Arthritis Res Ther       Date:  2005-07-28       Impact factor: 5.156

10.  Cells of the synovium in rheumatoid arthritis. Macrophages.

Authors:  Raimund W Kinne; Bruno Stuhlmüller; Gerd-R Burmester
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.